![Figure 1: PET scan at screening (A), 5 months (B) and 8 months on treatment (C). CDK9 INHIBITORS](https://www.oncotarget.net/wp-content/uploads/2023/08/Screen-Shot-2023-08-09-at-2.37.51-PM-300x163.png)
CDK9 Inhibitors: A Promising Combination Partner in Treating Hematological Malignancies
August 9, 2023
CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined with other therapeutic approaches.” BUFFALO, NY- August 9, 2023 –... read more